JPMorgan raised the firm’s price target on Amicus (FOLD) to $174 from $16 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology space.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FOLD: